자산수익률비율 (ROA)
2013년부터
계산
IQVIA Holdings Inc., ROA, 장기 추세계산
| ROA | = | 100 | × | IQVIA Holdings Inc.에 귀속되는 순이익1 | ÷ | 총 자산1 | |
|---|---|---|---|---|---|---|---|
| 2022. 12. 31. | 4.31% | = | 100 | × | 1,091) | ÷ | 25,337) |
| 2021. 12. 31. | 3.91% | = | 100 | × | 966) | ÷ | 24,689) |
| 2020. 12. 31. | 1.14% | = | 100 | × | 279) | ÷ | 24,564) |
| 2019. 12. 31. | 0.82% | = | 100 | × | 191) | ÷ | 23,251) |
| 2018. 12. 31. | 1.15% | = | 100 | × | 259) | ÷ | 22,549) |
| 2017. 12. 31. | 5.76% | = | 100 | × | 1,309) | ÷ | 22,742) |
| 2016. 12. 31. | 0.54% | = | 100 | × | 115) | ÷ | 21,208) |
| 2015. 12. 31. | 9.86% | = | 100 | × | 387) | ÷ | 3,926) |
| 2014. 12. 31. | 10.78% | = | 100 | × | 356) | ÷ | 3,306) |
| 2013. 12. 31. | 7.39% | = | 100 | × | 227) | ÷ | 3,067) |
보고서 기준: 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31).
1 US$ 단위: 백만 달러
경쟁사와의 비교
IQVIA Holdings Inc., ROA, 장기 추세, 경쟁사와의 비교
| IQVIA Holdings Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022. 12. 31. | 4.31% | 8.53% | 10.06% | 6.53% | 8.55% | 12.62% | 7.27% | 9.57% | 13.30% | 15.91% | 14.85% | 7.15% | 18.30% |
| 2021. 12. 31. | 3.91% | 7.88% | 9.63% | 6.40% | 7.73% | 11.44% | 9.16% | 11.47% | 12.35% | 12.11% | 31.75% | 8.12% | 17.44% |
| 2020. 12. 31. | 1.14% | 3.07% | 11.54% | -7.61% | 4.79% | 13.28% | 0.18% | 8.41% | 7.72% | 6.23% | 20.47% | 9.23% | 23.07% |
| 2019. 12. 31. | 0.82% | 8.84% | 13.13% | 2.65% | 4.85% | 21.17% | 8.74% | 9.59% | 11.66% | 9.72% | 14.29% | 6.33% | 14.15% |
| 2018. 12. 31. | 1.15% | 9.58% | 12.64% | 14.06% | 5.54% | 7.36% | 8.57% | 10.00% | 7.53% | 7.00% | 20.83% | 5.22% | 33.57% |
| 2017. 12. 31. | 5.76% | 7.50% | 2.48% | 3.00% | 5.34% | -0.45% | 6.58% | 0.83% | 2.72% | 12.40% | 13.67% | 3.93% | 7.43% |
| 2016. 12. 31. | 0.54% | 9.01% | 9.95% | 13.22% | 5.64% | 7.05% | 23.70% | 11.71% | 4.11% | 4.20% | 12.84% | 4.40% | -3.87% |
| 2015. 12. 31. | 9.86% | 9.70% | 9.69% | 4.93% | 6.96% | 6.77% | 34.93% | 11.55% | 4.36% | 4.16% | 11.34% | 4.83% | -22.26% |
| 2014. 12. 31. | 10.78% | 6.44% | 7.47% | 5.94% | 7.02% | 6.43% | 34.91% | 12.45% | 12.12% | 5.40% | 8.99% | 4.42% | -31.63% |
| 2013. 12. 31. | 7.39% | 14.14% | 7.68% | 6.64% | 7.77% | 13.29% | 13.67% | 10.42% | 4.17% | 12.78% | 14.38% | 4.00% | -19.19% |
보고서 기준: 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31).
산업 부문과의 비교: 제약, 생명공학 및 생명과학
IQVIA Holdings Inc., ROA, 장기 추세, 산업 부문과 비교: 제약, 생명공학 및 생명과학
| IQVIA Holdings Inc. | 제약, 생명공학 및 생명과학 | |
|---|---|---|
| 2022. 12. 31. | 4.31% | 10.67% |
| 2021. 12. 31. | 3.91% | 10.42% |
| 2020. 12. 31. | 1.14% | 5.45% |
| 2019. 12. 31. | 0.82% | 9.02% |
| 2018. 12. 31. | 1.15% | 8.97% |
| 2017. 12. 31. | 5.76% | 5.28% |
| 2016. 12. 31. | 0.54% | 8.61% |
| 2015. 12. 31. | 9.86% | 8.93% |
| 2014. 12. 31. | 10.78% | 9.45% |
| 2013. 12. 31. | 7.39% | 9.46% |
보고서 기준: 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31).
업계와의 비교: 의료
IQVIA Holdings Inc., ROA, 장기 추세, 업계와의 비교: 의료
| IQVIA Holdings Inc. | 의료 | |
|---|---|---|
| 2022. 12. 31. | 4.31% | 8.43% |
| 2021. 12. 31. | 3.91% | 8.29% |
| 2020. 12. 31. | 1.14% | 5.45% |
| 2019. 12. 31. | 0.82% | 7.18% |
| 2018. 12. 31. | 1.15% | 6.22% |
| 2017. 12. 31. | 5.76% | 5.24% |
| 2016. 12. 31. | 0.54% | 6.99% |
| 2015. 12. 31. | 9.86% | 7.36% |
| 2014. 12. 31. | 10.78% | 8.16% |
| 2013. 12. 31. | 7.39% | 8.27% |
보고서 기준: 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31).